Evidence map›Paper›PMID 37876818›Full record

ArticleiScience2023

A multi-center performance assessment for automated histopathological classification and grading of glioma using whole slide images.

Lei Jin, Tianyang Sun, Xi Liu, Zehong Cao, Yan Liu, Hong Chen, Yixin Ma, Jun Zhang, Yaping Zou, Yingchao Liu and 3 more

Abstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lei JinGlioma Surgery Division, Neurologic Surgery Department, Huashan Hospital Fudan University, Shanghai 200040, China.
Tianyang SunDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd, Shanghai 200030, China.
Xi LiuGlioma Surgery Division, Neurologic Surgery Department, Huashan Hospital Fudan University, Shanghai 200040, China.
Zehong CaoDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd, Shanghai 200030, China.
Yan LiuGlioma Surgery Division, Neurologic Surgery Department, Huashan Hospital Fudan University, Shanghai 200040, China.
Hong ChenNational Center for Neurological Disorders, Huashan Hospital Fudan University, Shanghai 200040, China.
Yixin MaGlioma Surgery Division, Neurologic Surgery Department, Huashan Hospital Fudan University, Shanghai 200040, China.
Jun ZhangWuhan Zhongji Biotechnology Co., Ltd, Wuhan 430206, China.
Yaping ZouWuhan Zhongji Biotechnology Co., Ltd, Wuhan 430206, China.
Yingchao LiuDepartment of Neurosurgery, The Provincial Hospital Affiliated to Shandong First Medical University, Shandong 250021, China.
Feng ShiDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd, Shanghai 200030, China.
Dinggang ShenDepartment of Research and Development, Shanghai United Imaging Intelligence Co., Ltd, Shanghai 200030, China.
Jinsong WuGlioma Surgery Division, Neurologic Surgery Department, Huashan Hospital Fudan University, Shanghai 200040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate pathological classification and grading of gliomas is crucial in clinical diagnosis and treatment. The application of deep learning techniques holds promise for automated histological pathology diagnosis. In this study, we collected 733 whole slide images from four medical centers, of which 456 were used for model training, 150 for internal validation, and 127 for multi-center testing. The study includes 5 types of common gliomas. A subtask-guided multi-instance learning image-to-label training pipeline was employed. The pipeline leveraged "patch prompting" for the model to converge with reasonable computational cost. Experiments showed that an overall accuracy of 0.79 in the internal validation dataset. The performance on the multi-center testing dataset showed an overall accuracy to 0.73. The findings suggest a minor yet acceptable performance decrease in multi-center data, demonstrating the model's strong generalizability and establishing a robust foundation for future clinical applications.

Indexed as

CancerComputational bioinformaticsHealth informaticsPathology

Identifiers

PMID37876818
PMCPMC10590813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.